Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Italy: the most frequently diagnosed cancers among males 2018

The most frequently diagnosed cancers among males in Italy as of 2018*

by Statista Research Department, last edited Sep 28, 2018
Italy: the most frequently diagnosed cancers among males 2018 This statistic depicts the most frequently diagnosed cancers among males in Italy as of 2018. The figures refer to the share of specific tumors out of the total number of cancers diagnosed among males. According to the source, prostate cancer registered the highest incidence among males (18 percent), followed by colorectal tumor (15 percent).
Show more

The most frequently diagnosed cancers among males in Italy as of 2018*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Cancer in Italy"
  • Incidence
The most important statistics
  • Screening
  • Mortality
  • Care and treatments
  • Research and fundraising
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.